These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 15127878

  • 1. Renal vascular resistance and renin-angiotensin system in the pathogenesis of early hypertension in autosomal dominant polycystic kidney disease.
    Ramunni A, Saracino A, Esposito T, Saliani MT, Coratelli P.
    Hypertens Res; 2004 Apr; 27(4):221-5. PubMed ID: 15127878
    [Abstract] [Full Text] [Related]

  • 2. Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members.
    Barrett BJ, Foley R, Morgan J, Hefferton D, Parfrey P.
    Kidney Int; 1994 Oct; 46(4):1118-23. PubMed ID: 7861706
    [Abstract] [Full Text] [Related]

  • 3. Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease.
    Lawson CR, Doulton TW, MacGregor GA.
    J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):139-45. PubMed ID: 17094050
    [Abstract] [Full Text] [Related]

  • 4. Sympathetic activity and blood pressure pattern in autosomal dominant polycystic kidney disease hypertensives.
    Cerasola G, Vecchi M, Mulè G, Cottone S, Mangano MT, Andronico G, Contorno A, Parrino I, Renda F, Pavone G.
    Am J Nephrol; 1998 Sep; 18(5):391-8. PubMed ID: 9730562
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
    Schrier RW.
    J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
    [Abstract] [Full Text] [Related]

  • 7. Renal vascular resistance in autosomal dominant polycystic kidney disease. Evaluation with color Doppler ultrasound.
    Brkljacic B, Sabljar-Matovinovic M, Putarek K, Soldo D, Morovic-Vergles J, Hauser M.
    Acta Radiol; 1997 Sep; 38(5):840-6. PubMed ID: 9332241
    [Abstract] [Full Text] [Related]

  • 8. Role of renin-angiotensin-aldosterone system and of sympathetic activity in arterial hypertension associated with autosomal dominant polycystic kidney disease.
    Cerasola G, Li Vecchi M, Mulé G, Cottone S, Mangano MT, Andronico G, Contomo A, Parrino IA, Renda F, Pavone G, Scialabba A.
    Contrib Nephrol; 1997 Sep; 122():22-7. PubMed ID: 9399032
    [No Abstract] [Full Text] [Related]

  • 9. Hypertension and renal injury in experimental polycystic kidney disease.
    Kennefick TM, Al-Nimri MA, Oyama TT, Thompson MM, Kelly FJ, Chapman JG, Anderson S.
    Kidney Int; 1999 Dec; 56(6):2181-90. PubMed ID: 10594794
    [Abstract] [Full Text] [Related]

  • 10. A link between the intrarenal renin angiotensin system and hypertension in autosomal dominant polycystic kidney disease.
    Kocyigit I, Yilmaz MI, Unal A, Ozturk F, Eroglu E, Yazici C, Orscelik O, Sipahioglu MH, Tokgoz B, Oymak O.
    Am J Nephrol; 2013 Dec; 38(3):218-25. PubMed ID: 23988725
    [Abstract] [Full Text] [Related]

  • 11. [Relationship between renal size and blood pressure profile in patients with autosomal dominant polycystic kidney disease without renal failure].
    Sans Atxer L, Roca-Cusachs A, Torra R, Calero F, Arias P, Ballarin J, Fernández-Llama P.
    Nefrologia; 2010 Dec; 30(5):567-72. PubMed ID: 20882096
    [Abstract] [Full Text] [Related]

  • 12. Autoregulation of renal blood flow and pressure-dependent renin release in autosomal dominant polycystic kidney disease of rats.
    Braun C, Lüdicke C, Rebsch W, Gretz N, van der Woude FJ, Rohmeiss P.
    Nephrol Dial Transplant; 1996 Dec; 11 Suppl 6():52-7. PubMed ID: 9044329
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease.
    Seeman T, Dusek J, Vondrichová H, Kyncl M, John U, Misselwitz J, Janda J.
    Blood Press Monit; 2003 Jun; 8(3):107-10. PubMed ID: 12900587
    [Abstract] [Full Text] [Related]

  • 15. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.
    Chapman AB, Johnson A, Gabow PA, Schrier RW.
    N Engl J Med; 1990 Oct 18; 323(16):1091-6. PubMed ID: 2215576
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease.
    Rahbari-Oskoui F, Williams O, Chapman A.
    Nephrol Dial Transplant; 2014 Dec 18; 29(12):2194-201. PubMed ID: 24463189
    [Abstract] [Full Text] [Related]

  • 17. [Blood pressure, functional and morphological study of kidneys in children with autosomal dominant polycystic kidney disease].
    Seeman T, Vondrichová H, Strízová J, Sikut M, Janda J, Schärer K.
    Cas Lek Cesk; 1999 Mar 15; 138(6):178-84. PubMed ID: 10510532
    [Abstract] [Full Text] [Related]

  • 18. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease.
    Loghman-Adham M, Soto CE, Inagami T, Cassis L.
    Am J Physiol Renal Physiol; 2004 Oct 15; 287(4):F775-88. PubMed ID: 15187005
    [Abstract] [Full Text] [Related]

  • 19. Screening of QTc interval and global autonomic activity in autosomal dominant polycystic kidney disease and atherosclerotic renal artery stenosis hypertensive patients.
    Lai S, Perrotta AM, Bagordo D, Mazzaferro S, Menè P, Gigante A, Tinti F, Galani A, Cianci R.
    Eur Rev Med Pharmacol Sci; 2021 Oct 15; 25(20):6333-6338. PubMed ID: 34730214
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.